Document Detail

Absence of interaction between oxcarbazepine and erythromycin.
MedLine Citation:
PMID:  1414219     Owner:  NLM     Status:  MEDLINE    
When erythromycin (ERY) is co-administrated with the antiepileptic carbamazepine (CBZ), a drug interaction may cause an increase in CBZ plasma concentrations, which can result in CBZ related toxic symptoms. This cross-over study was designated to investigate whether ERY influences the pharmacokinetics of the new antiepileptic oxcarbazepine (OXC) and its metabolites. In 8 healthy volunteers there were no significant differences in AUC, peak plasma concentrations or time to peak concentration when OXC was administered either with or without ERY. The results of this study suggest that OXC may offer an important advantage over CBZ especially when concomitant therapy with ERY is required.
T Keränen; J Jolkkonen; P K Jensen; G P Menge; P Andersson
Related Documents :
619359 - Sex differences in diazepam protein binding in patients with renal insufficiency.
20040899 - Hydroxyzine and cetirizine interfere with the pentina carbamazepine assay but not with ...
21877169 - Eculizumab in atypical hemolytic uremic syndrome: long-term clinical course and histolo...
1122689 - Diphenylhydantoin elimination kinetics in overdosed children.
21755509 - Increased serum interleukin-17 levels in patients with myasthenia gravis.
1628589 - Phenytoin pharmacokinetics: before and after folic acid administration.
1537309 - Distribution and characterization of immunoreactive corticostatin in the hypothalamic-p...
650539 - Plasma vasopressin levels during hypoxaemia and the cardiovascular effects of exogenous...
9195209 - A case of robinow syndrome accompanied by partial growth hormone insufficiency treated ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Acta neurologica Scandinavica     Volume:  86     ISSN:  0001-6314     ISO Abbreviation:  Acta Neurol. Scand.     Publication Date:  1992 Aug 
Date Detail:
Created Date:  1992-10-29     Completed Date:  1992-10-29     Revised Date:  2013-08-21    
Medline Journal Info:
Nlm Unique ID:  0370336     Medline TA:  Acta Neurol Scand     Country:  DENMARK    
Other Details:
Languages:  eng     Pagination:  120-3     Citation Subset:  IM    
Department of Pharmacology and Toxicology, University of Kuopio, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticonvulsants / pharmacokinetics,  toxicity*
Carbamazepine / analogs & derivatives*,  pharmacokinetics,  toxicity
Dose-Response Relationship, Drug
Drug Interactions
Erythromycin / pharmacokinetics,  toxicity*
Metabolic Clearance Rate / drug effects
Reg. No./Substance:
0/Anticonvulsants; 114-07-8/Erythromycin; 298-46-4/Carbamazepine; VZI5B1W380/oxcarbazepine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Myasthenia gravis in Hong Kong Chinese. 1. Epidemiology and adult disease.
Next Document:  Neuropsychological assessment in MS: clinical, neurophysiological and neuroradiological relationship...